Global Vital Organs Support Systems and Medical Bionics Market, By Vital Organ Support Systems (Artificial Heart, Artificial Kidney, Artificial Pancreas, Artificial Urinary Bladder, Artificial Lungs, and Artificial Liver), By Medical Bionics (Bionic Eye, Ear Bionics, Orthopedic Bionics, Cardiac Bionics, and Neural Bionics), By End User (Hospitals, Ambulatory Surgical Centers, and Others) and opportunities and forecast 2023-2030
Vital Organs Support Systems and Medical Bionics Market Overview
The Organ Support System includes artificial organs which are designed to perform the function of natural human organs. They are used as a substitute for lost body organs, replacement of the damaged organ, and support to the existing organs. Medical bionics is the study of mechanical systems that replicate parts of living organisms. Owing to various benefits such as cost-effective alternatives for curing multiple diseases, reduced risk of organ rejection, and reducing dependency on human donors. These benefits are projected to enhance the growth of vital organ support systems and the medical bionics market.
The other important factors such as the increasing number of patients suffering from chronic diseases and technological advancements in medical devices boost the growth of the market. Furthermore, High demand has been witnessed from patients for organ transplantation surgery, but the number of donors available to fulfil this demand is limited. As a result, a wider supply-demand gap, which lifts the growth of the global vital organs support systems and medical bionics market.
On the other hand, the high cost of treatment and strict approval process hampering the market development. Also, increasing technological advancements in the artificial organ sector are predictable to provide new opportunities for the market during the forecast period.
Vital Organs Support Systems and Medical Bionics Market Segment Overview
Based on end-user, the hospital segment accounted for the largest segmental revenue of the market in 2020. This is attributed to the various support departments, such as MRI suites and ICUs, that are available. Additionally, every day in the United States, 21 people die waiting for an organ and more than 120,048 men, women, and children await life-saving organ transplants.
Vital Organs Support Systems and Medical Bionics Market Regional Overview
North America dominated the vital organs support systems and medical bionics market in the year 2020. The factors such as growth in the geriatric population and lack of organs donor are driving the growth of the target market in the region. The market of the Asia Pacific is projected to grow at the fastest rate owing to the rising incidence of chronic disorders, increase in R&D expenditure, and government & private sector initiatives to increase awareness about artificial organs transplantation.
Vital Organs Support Systems and Medical Bionics Market Competitor overview
Major players operating in the industry are focusing on R&D to manufacture safer products for patient compliance and safety. Companies are engrossed in collaborations, mergers & acquisitions to improve the market share.
In January 2020, Medtronic plc announced it has received CE (Conformité Européenne) Mark for its Cobalt and Crome portfolio of implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy-defibrillators (CRT-D).
In March 2019, Baxter International Inc., is committed to advancing surgical innovation and announced it has completed its acquisition of two hemostat and sealant products from Mallinckrodt plc. RECOTHROM Thrombin topical (Recombinant) is the first and only stand-alone recombinant thrombin and PREVELEAK Surgical Sealant is used in vascular reconstruction.
In October 2018, Cochlear Limited announced the next phase in its long-term research and development program towards a totally implantable cochlear implant, with the start of a further clinical feasibility study. The development of totally implantable cochlear implant technology is complex, and a commercially available product is not expected for years; however, it remains a long-term development goal for Cochlear.
Vital Organs Support Systems and Medical Bionics Market, Key Players
Baxter International Inc.
Cochlear Ltd
Edwards Lifesciences Corporation
Heartware International Inc
Abbott Laboratories
Abiomed, Inc.
Asahi Kasei Corporation
Boston Scientific Corporation,
Jarvik Heart, Inc.
Medtronic Plc.
Össur Americas, Inc.
Second Sight Medical Products, Inc.
SynCardia Systems LLC.
Getinge AB
LivaNova PLC
Fresenius Medical Care AG & Co. KGaA
Heartware International Inc.
BiVACOR
Vital Organs Support Systems and Medical Bionics Market Segmentation
Vital Organs Support Systems and Medical Bionics Market, By Vital Organs Support Systems
Artificial Heart
Artificial Kidney
Artificial Pancreas
Artificial Urinary Bladder
Artificial Lungs
Artificial Liver
Vital Organs Support Systems and Medical Bionics Market, By Medical Bionics
Bionic Eye
Ear Bionics
Cochlear Implants
Bone Anchored Hearing Systems
Auditory Brainstem Implants
Orthopedic Bionics
Upper Limb
Lower Limb
Exoskeleton
Electrical Bone Growth Stimulators
Cardiac Bionics
Pacemaker
Ventricular Assist Device
Artificial Heart Valves
Neural Bionics
Internal Neurostimulators
External Neurostimulators
Vital Organs Support Systems and Medical Bionics Market, By End User
Hospitals
Ambulatory Surgical Centers
Others
Vital Organs Support Systems and Medical Bionics market, By Region
North America
US
Canada
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
South America
Brazil
Argentina
Rest of South America
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Key Emerging Trends – For Major Countries
4.2. Latest Technological Advancement
4.3. Regulatory Landscape
4.4. Industry SWOT Analysis
4.5. Porters Five Forces Analysis
5. Global Vital Organs Support Systems and Medical Bionics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Vital Organs Support Systems
5.2.1. Artificial Heart
5.2.2. Artificial Kidney
5.2.3. Artificial Pancreas
5.2.4. Artificial Urinary Bladder
5.2.5. Artificial Lungs
5.2.6. Artificial Liver
5.3. Market Analysis, Insights and Forecast – By Medical Bionics
5.3.1. Bionic Eye
5.3.2. Ear Bionics
5.3.2.1. Cochlear Implants
5.3.2.2. Bone Anchored Hearing Systems
5.3.2.3. Auditory Brainstem Implants
5.3.3. Orthopedic Bionics
5.3.3.1. Upper Limb
5.3.3.2. Lower Limb
5.3.3.3. Exoskeleton
5.3.3.4. Electrical Bone Growth Stimulators
5.3.4. Cardiac Bionics
5.3.4.1. Pacemaker
5.3.4.2. Ventricular Assist Device
5.3.4.3. Artificial Heart Valves
5.3.5. Neural Bionics
5.3.5.1. Internal Neurostimulators
5.3.5.2. External Neurostimulators
5.4. Market Analysis, Insights and Forecast – By End User
5.4.1. Hospitals
5.4.2. Ambulatory Surgical Centers
5.4.3. Others
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Latin America
5.5.3. Europe
5.5.4. Asia Pacific
5.5.5. Middle East and Africa
6. North America Vital Organs Support Systems and Medical Bionics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Vital Organs Support Systems
6.2.1. Artificial Heart
6.2.2. Artificial Kidney
6.2.3. Artificial Pancreas
6.2.4. Artificial Urinary Bladder
6.2.5. Artificial Lungs
6.2.6. Artificial Liver
6.3. Market Analysis, Insights and Forecast – By Medical Bionics
6.3.1. Bionic Eye
6.3.2. Ear Bionics
6.3.2.1. Cochlear Implants
6.3.2.2. Bone Anchored Hearing Systems
6.3.2.3. Auditory Brainstem Implants
6.3.3. Orthopedic Bionics
6.3.3.1. Upper Limb
6.3.3.2. Lower Limb
6.3.3.3. Exoskeleton
6.3.3.4. Electrical Bone Growth Stimulators
6.3.4. Cardiac Bionics
6.3.4.1. Pacemaker
6.3.4.2. Ventricular Assist Device
6.3.4.3. Artificial Heart Valves
6.3.5. Neural Bionics
6.3.5.1. Internal Neurostimulators
6.3.5.2. External Neurostimulators
6.4. Market Analysis, Insights and Forecast – By End User
6.4.1. Hospitals
6.4.2. Ambulatory Surgical Centers
6.4.3. Others
6.5. Market Analysis, Insights and Forecast – By Country
6.5.1. U.S.
6.5.2. Canada
7. Latin America Vital Organs Support Systems and Medical Bionics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Vital Organs Support Systems
7.2.1. Artificial Heart
7.2.2. Artificial Kidney
7.2.3. Artificial Pancreas
7.2.4. Artificial Urinary Bladder
7.2.5. Artificial Lungs
7.2.6. Artificial Liver
7.3. Market Analysis, Insights and Forecast – By Medical Bionics
7.3.1. Bionic Eye
7.3.2. Ear Bionics
7.3.2.1. Cochlear Implants
7.3.2.2. Bone Anchored Hearing Systems
7.3.2.3. Auditory Brainstem Implants
7.3.3. Orthopedic Bionics
7.3.3.1. Upper Limb
7.3.3.2. Lower Limb
7.3.3.3. Exoskeleton
7.3.3.4. Electrical Bone Growth Stimulators
7.3.4. Cardiac Bionics
7.3.4.1. Pacemaker
7.3.4.2. Ventricular Assist Device
7.3.4.3. Artificial Heart Valves
7.3.5. Neural Bionics
7.3.5.1. Internal Neurostimulators
7.3.5.2. External Neurostimulators
7.4. Market Analysis, Insights and Forecast – By End User
7.4.1. Hospitals
7.4.2. Ambulatory Surgical Centers
7.4.3. Others
7.5. Insights and Forecast – By Country
7.5.1. Brazil
7.5.2. Mexico
7.5.3. Rest of Latin America
8. Europe Vital Organs Support Systems and Medical Bionics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Vital Organs Support Systems
8.2.1. Artificial Heart
8.2.2. Artificial Kidney
8.2.3. Artificial Pancreas
8.2.4. Artificial Urinary Bladder
8.2.5. Artificial Lungs
8.2.6. Artificial Liver
8.3. Market Analysis, Insights and Forecast – By Medical Bionics
8.3.1. Bionic Eye
8.3.2. Ear Bionics
8.3.2.1. Cochlear Implants
8.3.2.2. Bone Anchored Hearing Systems
8.3.2.3. Auditory Brainstem Implants
8.3.3. Orthopedic Bionics
8.3.3.1. Upper Limb
8.3.3.2. Lower Limb
8.3.3.3. Exoskeleton
8.3.3.4. Electrical Bone Growth Stimulators
8.3.4. Cardiac Bionics
8.3.4.1. Pacemaker
8.3.4.2. Ventricular Assist Device
8.3.4.3. Artificial Heart Valves
8.3.5. Neural Bionics
8.3.5.1. Internal Neurostimulators
8.3.5.2. External Neurostimulators
8.4. Market Analysis, Insights and Forecast – By End User
8.4.1. Hospitals
8.4.2. Ambulatory Surgical Centers
8.4.3. Others
8.5. Market Analysis, Insights and Forecast – By Country
8.5.1. UK
8.5.2. Germany
8.5.3. France
8.5.4. Italy
8.5.5. Spain
8.5.6. Russia
8.5.7. Rest of Europe
9. Asia Pacific Vital Organs Support Systems and Medical Bionics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Vital Organs Support Systems
9.2.1. Artificial Heart
9.2.2. Artificial Kidney
9.2.3. Artificial Pancreas
9.2.4. Artificial Urinary Bladder
9.2.5. Artificial Lungs
9.2.6. Artificial Liver
9.3. Market Analysis, Insights and Forecast – By Medical Bionics
9.3.1. Bionic Eye
9.3.2. Ear Bionics
9.3.2.1. Cochlear Implants
9.3.2.2. Bone Anchored Hearing Systems
9.3.2.3. Auditory Brainstem Implants
9.3.3. Orthopedic Bionics
9.3.3.1. Upper Limb
9.3.3.2. Lower Limb
9.3.3.3. Exoskeleton
9.3.3.4. Electrical Bone Growth Stimulators
9.3.4. Cardiac Bionics
9.3.4.1. Pacemaker
9.3.4.2. Ventricular Assist Device
9.3.4.3. Artificial Heart Valves
9.3.5. Neural Bionics
9.3.5.1. Internal Neurostimulators
9.3.5.2. External Neurostimulators
9.4. Market Analysis, Insights and Forecast – By End User
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Centers
9.4.3. Others
9.5. Market Analysis, Insights and Forecast – By Country
9.5.1. China
9.5.2. India
9.5.3. Japan
9.5.4. Australia
9.5.5. South East Asia
9.5.6. Rest of Asia Pacific
10. Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
10.1. Key Findings / Summary
10.2. Market Analysis, Insights and Forecast – By Vital Organs Support Systems
10.2.1. Artificial Heart
10.2.2. Artificial Kidney
10.2.3. Artificial Pancreas
10.2.4. Artificial Urinary Bladder
10.2.5. Artificial Lungs
10.2.6. Artificial Liver
10.3. Market Analysis, Insights and Forecast – By Medical Bionics
10.3.1. Bionic Eye
10.3.2. Ear Bionics
10.3.2.1. Cochlear Implants
10.3.2.2. Bone Anchored Hearing Systems
10.3.2.3. Auditory Brainstem Implants
10.3.3. Orthopedic Bionics
10.3.3.1. Upper Limb
10.3.3.2. Lower Limb
10.3.3.3. Exoskeleton
10.3.3.4. Electrical Bone Growth Stimulators
10.3.4. Cardiac Bionics
10.3.4.1. Pacemaker
10.3.4.2. Ventricular Assist Device
10.3.4.3. Artificial Heart Valves
10.3.5. Neural Bionics
10.3.5.1. Internal Neurostimulators
10.3.5.2. External Neurostimulators
10.4. Market Analysis, Insights and Forecast – By End User
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Others
10.5. Market Analysis, Insights and Forecast – By Country
10.5.1. GCC
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Company Market Share Analysis, 2018
11.2. Key Industry Developments
11.3. Company Profile
11.4. Baxter International Inc.
11.4.1. Business Overview
11.4.2. Segment 1 & Service Offering
11.4.3. Overall Revenue
11.4.4. Geographic Presence
11.4.5. Recent Development
*Similar details will be provided for the following companies
11.5. Cochlear Ltd
11.6. Edwards Lifesciences Corporation
11.7. Heartware International Inc
11.8. Abbott Laboratories
11.9. Abiomed, Inc.
11.10. Asahi Kasei Corporation
11.11. Boston Scientific Corporation,
11.12. Jarvik Heart, Inc.
11.13. Medtronic Plc.
11.14. Össur Americas, Inc.
11.15. Second Sight Medical Products, Inc.
11.16. SynCardia Systems LLC.
11.17. Getinge AB
11.18. LivaNova PLC
11.19. Fresenius Medical Care AG & Co. KGaA
11.20. Heartware International Inc.
List of Figures
Figure 1: Global Vital Organs Support Systems and Medical Bionics Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Vital Organs Support Systems and Medical Bionics Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Revenue (USD Billion) Forecast, by Country, 2016-2027